Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall aprotinin-trasylolA recent January 2006 study indicates a strong link between heart surgery drug aprotinin and kidney failure . In addition to kidney failure, aprotinin has also been linked to a higher risk of heart attack, heart disease, stroke, brain disease, and death.
The Study
A study published in the New England Medical Journal suggests that aprotinin, a drug that has been on the market for 13 years, can drastically increase the risk of serious and potentially deadly side effects. Researchers Dr. Dennis Mangano and colleagues at the Ischemic Research and Education Foundation in California have likened the results of this study to those that prompted the recall of Vioxx, a once-popular painkiller now linked to heart attack and stroke.
Aprotinin
Aprotinin, made by Bayer Pharmaceuticals under the name Trasylol, is used to reduce bleeding and the need for transfusion in patients undergoing heart surgery. Early clinical findings established a link between aprotinin and abnormal kidney function, yet no further studies were conducted to determine aprotinin''s kidney toxicity. This drug has been administered to over one million people in more than 60 countries.
Kidney Failure
Kidney failure (or renal failure) is the inability of the kidneys to properly filter waste out of the blood. Symptoms of kidney failure can include fluid retention (swelling and puffiness), cola-colored urine, reduced urine output, fatigue, decreased ability to focus, loss of appetite, nausea, and general itchiness. Rapid heart rate and lightheadedness may also occur. In cases of kidney failure, dialysis is often required to help rid the body of excess waste products and built-up fluids. Kidney dialysis is a major medical process, which poses significant risks of its own.
Aprotinin and Kidney Failure
According to the recent study, aprotinin can double the risk of kidney failure requiring dialysis. The increased risk of aprotinin kidney failure, however, was NOT discovered in patients taking cheaper generic alternatives: aminocaproic acid and tranexamic acid. The research team estimates that 10,000 people may currently be on dialysis due to aprotinin and kidney failure.
Mangano reports that if generic drugs are given instead of aprotinin, more than 11,050 kidney dialysis complications could be prevented, $1 billion in healthcare costs could be saved, and the cost of medication would be reduced by $250 million.
So What Now?
Given the evidence of aprotinin and kidney failure risks (and other serious risks), many medical experts say that doctors can no longer administer aprotinin in good conscience . Mangano states that he would never give aprotinin given the risks and the available alternatives. He says that if a doctor still wants to use aprotinin, “the least that should be done is to inform the patient that the risk of going on dialysis is increased two- to three-fold and there are alternatives.”
Have you suffered due to aprotinin and kidney failure?
If you or a loved one has been administered aprotinin (Trasylol) during heart surgery and you are concerned or have been injured by aprotinin and kidney failure, you may be eligible to collect damages for your losses and suffering. Please contact us today to speak with a qualified and experience attorney about aprotinin and kidney failure today.
A rigorous study involving the heart surgery drug Trasylol is likely to seal the drug’s fate, as researchers are left with little doubt of the greater ...
The heart surgery drug, Trasylol, increases the risk of death and kidney damage in patients, two new studies have confirmed.
Trasylol (aprotinin) is given to patien...
Sales of the heart surgery drug Trasylol are being suspended as concerns continue to mount over the increased risk of death, the Food and Drug Administration announced Monday...